These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 29141973)

  • 1. Energy Metabolism Profile in Individuals with Prader-Willi Syndrome and Implications for Clinical Management: A Systematic Review.
    Alsaif M; Elliot SA; MacKenzie ML; Prado CM; Field CJ; Haqq AM
    Adv Nutr; 2017 Nov; 8(6):905-915. PubMed ID: 29141973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Energy expenditure and physical activity in Prader-Willi syndrome: comparison with obese subjects.
    Butler MG; Theodoro MF; Bittel DC; Donnelly JE
    Am J Med Genet A; 2007 Mar; 143A(5):449-59. PubMed ID: 17103434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary Energy Intake, Body Composition and Resting Energy Expenditure in Prepubertal Children with Prader-Willi Syndrome before and during Growth Hormone Treatment: A Randomized Controlled Trial.
    Bakker NE; Siemensma EP; Koopman C; Hokken-Koelega AC
    Horm Res Paediatr; 2015; 83(5):321-31. PubMed ID: 25764996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fat-Free Mass Is Better Related to Serum Uric Acid Than Metabolic Homeostasis in Prader-Willi Syndrome.
    Marzullo P; Mele C; Minocci A; Mai S; Scacchi M; Sartorio A; Aimaretti G; Grugni G
    Nutrients; 2020 Aug; 12(9):. PubMed ID: 32854398
    [No Abstract]   [Full Text] [Related]  

  • 5. Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi Syndrome.
    Bekx MT; Carrel AL; Shriver TC; Li Z; Allen DB
    J Pediatr; 2003 Sep; 143(3):372-6. PubMed ID: 14517523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reduced-energy intake, well-balanced diet improves weight control in children with Prader-Willi syndrome.
    Miller JL; Lynn CH; Shuster J; Driscoll DJ
    J Hum Nutr Diet; 2013 Feb; 26(1):2-9. PubMed ID: 23078343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods of Determining Energy Expenditure in Individuals with Prader-Willi Syndrome: A Systematic Literature Review.
    Halilagic A; Longmore DK; Gilbertson H; Moschonis G
    Nutrients; 2024 Jul; 16(13):. PubMed ID: 38999908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Energy expenditure at rest and during sleep in children with Prader-Willi syndrome is explained by body composition.
    van Mil EA; Westerterp KR; Gerver WJ; Curfs LM; Schrander-Stumpel CT; Kester AD; Saris WH
    Am J Clin Nutr; 2000 Mar; 71(3):752-6. PubMed ID: 10702169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity related energy expenditure in children and adolescents with Prader-Willi syndrome.
    van Mil EG; Westerterp KR; Kester AD; Curfs LM; Gerver WJ; Schrander-Stumpel CT; Saris WH
    Int J Obes Relat Metab Disord; 2000 Apr; 24(4):429-34. PubMed ID: 10805499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Obesity Associated with Altered Energy Expenditure?
    Carneiro IP; Elliott SA; Siervo M; Padwal R; Bertoli S; Battezzati A; Prado CM
    Adv Nutr; 2016 May; 7(3):476-87. PubMed ID: 27184275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial metabolism in adults with Prader-Willi syndrome.
    Purtell L; Viardot A; Sze L; Loughnan G; Steinbeck K; Sainsbury A; Herzog H; Smith A; Campbell LV
    Obesity (Silver Spring); 2015 Jun; 23(6):1159-65. PubMed ID: 25958986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome.
    Goldstone AP; Brynes AE; Thomas EL; Bell JD; Frost G; Holland A; Ghatei MA; Bloom SR
    Am J Clin Nutr; 2002 Mar; 75(3):468-75. PubMed ID: 11864851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irisin levels in genetic and essential obesity: clues for a potential dual role.
    Mai S; Grugni G; Mele C; Vietti R; Vigna L; Sartorio A; Aimaretti G; Scacchi M; Marzullo P
    Sci Rep; 2020 Jan; 10(1):1020. PubMed ID: 31974460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained benefits of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome are dose-dependent.
    Carrel AL; Myers SE; Whitman BY; Allen DB
    J Pediatr Endocrinol Metab; 2001; 14(8):1097-105. PubMed ID: 11592566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of sleep disorders in Prader-Willi syndrome.
    Duis J; Pullen LC; Picone M; Friedman N; Hawkins S; Sannar E; Pfalzer AC; Shelton AR; Singh D; Zee PC; Glaze DG; Revana A
    J Clin Sleep Med; 2022 Jun; 18(6):1687-1696. PubMed ID: 35172921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomic profiling of Prader-Willi syndrome compared with essential obesity.
    Rigamonti AE; Polledri E; Favero C; Caroli D; Bondesan A; Grugni G; Mai S; Cella SG; Fustinoni S; Sartorio A
    Front Endocrinol (Lausanne); 2024; 15():1386265. PubMed ID: 38812813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
    Myers SE; Carrel AL; Whitman BY; Allen DB
    J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical leanness in the imprinting-centre deletion mouse model for Prader-Willi syndrome.
    Golding DM; Rees DJ; Davies JR; Relkovic D; Furby HV; Guschina IA; Hopkins AL; Davies JS; Resnick JL; Isles AR; Wells T
    J Endocrinol; 2017 Jan; 232(1):123-135. PubMed ID: 27799465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Genotype and Previous GH Treatment on Adiposity in Adults With Prader-Willi Syndrome.
    Coupaye M; Tauber M; Cuisset L; Laurier V; Bieth E; Lacorte JM; Oppert JM; Clément K; Poitou C
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4895-4903. PubMed ID: 27662437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.